Increased Suicide Attempts Seen in Parents With a Child Diagnosed With Cancer

18 Jan 2024
www.drugs.com
Clinical Result
THURSDAY, Jan. 18, 2024 -- There is an increased risk for parental suicide attempt during the first years after a child's cancer diagnosis, according to a study published online Jan. 16 in PLOS Medicine.
Qianwei Liu, M.D., Ph.D., from Southern Medical University in Guangzhou, China, and colleagues investigated the risk for suicide attempt and death by suicide in relation to having a child with cancer. The analysis included 106,005 parents with a child diagnosed with cancer in Denmark (1978 to 2016) or Sweden (1973 to 2014) and roughly 1.06 million matched unexposed parents.
The researchers found that during a median follow-up of 7.3 and 7.2 years for the exposed and unexposed parents, respectively, there was an increased risk seen for parental suicide attempt during the first years after a child's cancer diagnosis (hazard ratio [HR], 1.15). Risk was even higher when the child was aged 18 years or younger at diagnosis (HR, 1.25), when the child was diagnosed with a highly aggressive cancer (HR, 1.60), or when the child died due to cancer (HR, 1.63). However, this increased risk did not persist over time thereafter.
"Our findings suggest extended clinical awareness of suicide attempt among parents of children with cancer, especially during the first few years after cancer diagnosis," the authors write.
Abstract/Full Text
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.